Steris eyes best day in two years after upbeat outlook

Steris

15/05/2025 16:03

** Shares of medical-device co Steris STE.N up 8.3% at $246.47 and top S&P 500 .SPX performer on Thurs after qtrly report pleases

** STE on course for biggest daily pct gain since May 11, 2023, hits 8-mth high

** Dublin, Ireland firm late Weds forecast annual profit above consensus, banking on strength in its biggest segment that sells sterilization products

** It sees fiscal 2026 adj EPS of $9.90-$10.15 compared to the $9.87 analysts modeled, per LSEG data

** Co also posted Q4 top and bottom-line beat

** Of 8 analysts covering STE, recommendation breakdown is 5 "strong buy" or "buy" and 3 "hold" ratings; median PT is $263 - latest LSEG data

** With move on the session, stock up ~20% YTD vs 4% decline in S&P 500 Healthcare Equipment & Services index .SPLRCHC and 7% drop in S&P 500 Healthcare sector .SPXHC

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))